BRCA1 and familial ovarian cancer: Malignant transformation in BRCA-related familial ovarian cancer is thought to occur when the remaining wild-type allele undergoes pathogenic mutation or epigenetic silencing, thereby leaving only the germline BRCA1/2 mutant allele [18].